2 minute read
Celebrating a landmark year for CellPath
2019 was a fantastic year for all of us here at CellPath, with a record scoop of eight awards in just twelve months. Work began on our fourth CellNass warehouse and January saw the launch of our solvent delivery service CellSolv. Our successes reflect the hard work and commitment of our whole team and it was fantastic to have so many of our diverse achievements rewarded, and ultimately seeing us crowned as Welsh Business of the Year.
Throughout 2019, our CellNass service continued to grow from strength to strength, and the future looks bright as we have recently broken ground on a fourth warehouse. This major infrastructure investment will be built on our mid-Wales site and use exclusively local contractors. We look forward to welcoming customers to visit when circumstances allow. We also attended record numbers of conferences around the world, giving us the opportunity to meet both existing and potential customers face-to-face. We attended the Institute of Biomedical Science Congress in Birmingham, where we launched the LUMEA BxChip- an innovative method of processing needle core biopsies. The BxChip wasn’t the only surprise from Congress as we also received the award for Best Stand. IBMS Congress allowed us the opportunity to relay further information about the recently launched CellSolv service, which provides a convenient way for pathology laboratories to order and dispose of the solvents they regularly need. Making sure to consider the environmental impact of this business expansion, we have planned fuel efficient routes for our dedicated delivery van and we explore chemical recycling opportunities wherever possible. We certainly enjoyed ourselves in 2019 and were delighted to celebrate with so many other fantastic Welsh businesses. Though it is important to reflect on good times, like businesses all over the world, we now face a new challenge. The outbreak of coronavirus has caused significant additional pressure to the supply chain of medical goods, and we are proud to be doing what we can to minimise disruption to our valuable customers. As we supply the essential tools to make cancer diagnosis possible, we remain committed to supporting our customers whilst also protecting our staff and our local community by ensuring our mid-Wales premises are safe for all.
Upon hearing of the need for additional sanitisation products locally, we increased production capacity of the WHO formulation hand sanitiser, which has now been supplied to local businesses free of charge. We have also distributed additional hand sanitiser to our laboratory customers and have sourced a general purpose surface sanitiser with proven efficacy against SARS-
CoV-2.
We are fortunate to be a versatile business and were quickly able to re-purpose the use of our 3D printers, allowing us to produce protective face shields for key workers in the local area, including social housing, school hubs, funeral parlours and a local hospital.
We are proud of our ability to look after our staff and neighbours in these trying times, however, we have not forgotten the impact this crisis is having on our valuable NHS customers. For that reason, we made the decision to offer all NHS customers a price freeze for the financial year. We hope our efforts help to support our NHS and wish to reiterate our thanks for the patience, support and dedication of all of our customers around the world.
